Neuland Laboratories to hold its 41st AGM via video conferencing; shareholders to discuss dividend and key matters.
Neuland Laboratories Announces 41st AGM Via Video Conference, Includes Final Dividend and Record Date
Hyderabad, June 17, 2025 — Neuland Laboratories Ltd (BSE: 524558), India’s leading pharmaceutical solutions provider, has officially declared the date and time of its upcoming 41st Annual General Meeting (AGM). In the regulatory filing made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published a newspaper notice for the AGM, which will take place through video conferencing (VC) this year.
The AGM notice, as per the company’s filing with Bombay Stock Exchange (BSE), also includes significant information on shareholders record date and last dividend payment for the financial year.
Key Highlights from the Announcement
More Read
- AGM Number: 41st
- Mode of Meeting: Video Conference (VC)
- Notice Type: Newspaper Publication
- Company Name: Neuland Laboratories Ltd
- Stock Code (BSE): 524558
- Publication Date: June 17, 2025
Details of the AGM
On the issue of altering business operations and regulatory needs, Neuland Laboratories also made a choice to conduct its AGM on a virtual platform in order to allow shareholder interaction in a safe and comfortable manner. The time, date, and complete agenda of the AGM will be announced through the official notice given to the shareholders as well as posted on the company’s website.
The virtual AGM will allow registered shareholders to vote on key resolutions including approval of the accounts, reappointment of directors, and declaration of final dividend.
Record Date and Final Dividend
The record date, as specified in the published notice, will determine the eligibility of shareholders for the last dividend. Shareholders whose names appear in the register of the company on or prior to the record date will be entitled to receive the declared dividend.
Although the exact size of the dividend will probably be defined during the AGM, the company has consistently maintained a record of stable dividend payment, which reflects its shareholder value orientation.
Why This Matters
This update is significant for investors and stakeholders for several reasons:
- Shareholder Value: The declaration of a final dividend signals continued profitability and operational stability.
- Transparency: Conducting the AGM via video conferencing promotes transparency and accessibility.
- Regulatory Compliance: Adhering to SEBI’s Regulation 30 requirements demonstrates Neuland’s governance standards.
The announcement is part of Neuland Laboratories’ ongoing efforts to stay compliant, transparent, and accessible to its wide base of investors.
About Neuland Laboratories Ltd
Established in 1984 and having its corporate office in Hyderabad, Neuland Laboratories Ltd is a well-known pharmaceutical player dealing in Active Pharmaceutical Ingredients (APIs) and contract manufacturing. It caters to generic as well as innovator pharmaceutical firms globally.
Neuland established a reputation for high standards of quality, compliance with regulations, and innovative manufacturing practices. It continues to expand its global presence through strategic alliances and environmentally friendly operations.
Where to View the Official Notice
The full advertisement regarding the AGM and related details can be viewed on the BSE India website, or directly via the official company portal.
